HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glenn C Telling Selected Research

Prions

1/2022Tissue-specific biochemical differences between chronic wasting disease prions isolated from free-ranging white-tailed deer (Odocoileus virginianus).
1/2022North American and Norwegian Chronic Wasting Disease Prions Exhibit Different Potential for Interspecies Transmission and Zoonotic Risk.
1/2021Adaptive selection of a prion strain conformer corresponding to established North American CWD during propagation of novel emergent Norwegian strains in mice expressing elk or deer prion protein.
12/2020Studies in bank voles reveal strain differences between chronic wasting disease prions from Norway and North America.
1/2020Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination.
10/2019Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies.
1/2019Primary structural differences at residue 226 of deer and elk PrP dictate selection of distinct CWD prion strains in gene-targeted mice.
1/2019Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics.
1/2019Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
1/2018Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Glenn C Telling Research Topics

Disease

36Chronic Wasting Disease
01/2022 - 12/2004
23Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2019 - 01/2004
15Infections
01/2020 - 10/2006
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2008
7Bovine Spongiform Encephalopathy (Mad Cow Disease)
01/2018 - 01/2004
6Scrapie
01/2020 - 05/2004
5Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
01/2019 - 05/2004
2Brain Diseases (Brain Disorder)
01/2020 - 09/2008
2Disease Progression
01/2019 - 12/2013
1Spinal Cord Injuries (Spinal Cord Injury)
11/2020
1Kuru
01/2018
1Sporadic Creutzfeldt-Jakob Disease
01/2017
1Proteostasis Deficiencies
10/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2013
1Brain Injuries (Brain Injury)
06/2013
1Disease Susceptibility (Diathesis)
10/2012
1Body Weight (Weight, Body)
11/2011
1Alzheimer Disease (Alzheimer's Disease)
04/2011
1Asymptomatic Infections
11/2009
1Amyloid Plaque
12/2004

Drug/Important Bio-Agent (IBA)

46PrionsIBA
01/2022 - 05/2004
23Prion ProteinsIBA
01/2020 - 01/2004
14Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2008
6Peptide Hydrolases (Proteases)FDA Link
11/2020 - 05/2004
4Protein Isoforms (Isoforms)IBA
01/2020 - 06/2010
2calpastatinIBA
11/2020 - 06/2013
2EpitopesIBA
01/2020 - 10/2012
2Biological ProductsIBA
01/2019 - 10/2013
2Complement System Proteins (Complement)IBA
12/2017 - 12/2013
2Amyloid (Amyloid Fibrils)IBA
09/2015 - 04/2011
2CalpainIBA
06/2013 - 05/2004
2PrPSc ProteinsIBA
09/2011 - 06/2010
1CalciumIBA
11/2020
1Monoclonal AntibodiesIBA
01/2020
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2019
1VaccinesIBA
01/2018
1Pharmaceutical PreparationsIBA
04/2014
1Quinacrine (Mepacrine)IBA
04/2014
1TEMPOIBA
02/2014
1Glycoproteins (Glycoprotein)IBA
02/2014
1Amino AcidsFDA Link
10/2013
1Alanine (L-Alanine)FDA Link
10/2013
1Nucleic AcidsIBA
10/2013
1collapsin response mediator protein-2IBA
06/2013
1Voltage-Gated Sodium ChannelsIBA
06/2013
1SpectrinIBA
06/2013
1ClayIBA
01/2013
1Bentonite (Montmorillonite)IBA
01/2013
1Complement Receptors (Complement Receptor)IBA
11/2012
1LipidsIBA
11/2012
1Oxidants (Oxidizing Agents)IBA
11/2011
1Peptides (Polypeptides)IBA
04/2011
1AerosolsIBA
06/2010
14-O-carboxymethylascochlorinIBA
05/2010
1AntibodiesIBA
09/2008
1Codon (Codons)IBA
02/2008
1Methionine (L-Methionine)FDA Link
02/2008
1Leucine (L-Leucine)FDA Link
02/2008

Therapy/Procedure

1Therapeutics
01/2019
1Euthanasia (Mercy Killing)
06/2010
1Blood Transfusion (Blood Transfusions)
05/2010